Organization
Beijing Friendship Hospital
22 clinical trials
1 abstract
Clinical trial
Comparison of the Effects of Esketamine, Sufentanil, or Lidocaine Combined With Propofol on Tussis Reflection During Upper Gastroscopy: a Randomised, Two Centre, Three-blind, Controlled TrialStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Camrelizumab Combined With Apatinib and Capecitabine for Patients With Advanced Biliary Tract Cancer: a Phase 2, Single-arm, Prospective Study.Status: Completed, Estimated PCD: 2023-04-30
Clinical trial
Efficacy and Safety of Neoadjuvant Long-course Chemoradiation Plus Tislelizumab in Mid-low Locally Advanced Rectal Cancer: a Phase II, Multi-center, Open-label, Randomized Controlled Trial (POLARSTAR Trial)Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2026-12-01
Abstract
Neoadjuvant long-course chemoradiation plus PD1 blockade for locally advanced rectal cancer: Results of a phase 2, open-label, randomized controlled trial.Org: Beijing Friendship Hospital, Xuanwu Hospital, Beijing Chaoyang Hospital, Beijing Hospital,
Clinical trial
The Efficacy and Safety of Preoperative Neoadjuvant Chemoradiation Combined With PD-1 Inhibitor and PCSK9 Inhibitor in the Treatment of pMMR/MSS Locally Advanced Middle and Low Rectal Cancer: a Multicenter Study, Prospective, Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Clinical trial
Effect of Opioid-free Analgesia and Anesthesia on the Quality of Postoperative Recovery and Nausea Vomit in Patients Receiving Laparoscopic Sleeve GastrectomyStatus: Recruiting, Estimated PCD: 2025-03-31
Clinical trial
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin in pMMR/MSS Locally Advanced Middle and Low Rectal Cancer: An Open, Multi-center, Prospective, Single-arm Phase II Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Clinical trial
Teniposide Incorporating Bu/Cy Conditioning Regimen Followed by HSCT for HLH With Central Nervous System Involvement: a Prospective Single-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Clinical Study on Efficacy and Safety of GTP Regimen in the Treatment of Refractory/Recurrent Hemophagocytic LymphohistiocytosisStatus: Not yet recruiting, Estimated PCD: 2024-09-15
Clinical trial
Effect of Sacubitril/Valsartan on Cardiac Function Assessed by Cardiac Magnetic Resonance (CMR) in Hypertensive Patients Stratified by Body Mass Index (BMI): A Real World StudyStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
Efficacy and Safety of Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer: a Single-center, Retrospective, Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Clinical trial
Clinical Study on the Efficacy and Safety of Carrimycin Tablets in Hemophagocytic Lymphohistiocytosis Patients With Carbapenem-resistant InfectionsStatus: Not yet recruiting, Estimated PCD: 2026-08-30
Clinical trial
Thiotepa Incorporating TBI/Cy Conditioning Regimen Followed by HSCT for EBV-HLH With Central Nervous System Involvement: a Prospective Single-arm Clinical StudyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced Phase II Randomized Controlled Clinical Study of Middle and Low Rectal CancerStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
The Efficacy and Safety of L-DEP Regimen Combined With PD-1 Antibody an Induction Therapy for Epstein-Barr Virus (EBV)-Positive Lymphoma-associated Hemophagocytic LymphohistiocytosisStatus: Not yet recruiting, Estimated PCD: 2026-08-01
Clinical trial
Zanubrutinib Monotherapy in Patients With Hemophagocytic LymphohistiocytosisStatus: Completed, Estimated PCD: 2023-08-01
Clinical trial
Efficacy and Safety of Low Dose Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous NephropathyStatus: Recruiting, Estimated PCD: 2023-12-04
Clinical trial
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid TumorsStatus: Completed, Estimated PCD: 2022-10-31
Clinical trial
Role and Mechanism of Bifidobacterium Triple Viable Capsules in Improving Motor Symptoms in Patients With Mild to Moderate Parkinson's Disease: a Multicenter Randomized Clinical StudyStatus: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
A Single-arm Study Sponsored by Investigators to Evaluate the Efficacy and Safety of CM310 Recombinant Humanized Monoclonal Antibody Injection in Patients With Recurrent IgG4-related DiseasesStatus: Not yet recruiting, Estimated PCD: 2024-02-28
Clinical trial
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Locally Advanced Esophageal CarcinomaStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
To Evaluate the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy and Explore the Possible Mechanism by Using Functional Magnetic Resonance Imaging (fMRI)Status: Recruiting, Estimated PCD: 2025-09-30